Skip to main content

Table 3 Biochemical and haemodynamic measures at baseline, pre and post intervention for both groups

From: Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance

Group α-lipoic acid + exercise
(n = 12)
  α-lipoic acid only
(n = 12)
 
Time Baseline Pre intervention Post intervention Baseline Pre intervention Post intervention
Body mass (kg) 87.7 (18.7) 87.3 (18.9) 85.5 (17.4) 93.1 (14.3) 93.1 (14.3) 92.4 (14.0)
BMI (kg/m2) 31.6 (6.7) 31.4 (6.9) 30.7 (6.4) 32.8 (5.8) 32.8 (5.8) 32.5 (5.7)
Total body fat (%) 46.6 (6.9) 41.6 (5.5) 41.5 (5.4) 49.8 (11.6) 49.4 (11.2) 49.3 (11.8)
Waist circumference (cms) 105.8 (23.3) 100.6 (13.9) 96.1 (13.9) 104.9 (9.0) 104.9 (9.0) 102.7 (9.2)
Hip circumference (cms) 109.9 (13.9) 108.8 (16.0) 103.1 (13.1) 112.5 (12.7) 112.6 (12.8) 111.1 (12.9)
Total cholesterol (mmol.L-1) 5.5 (1.0) 5.5 (0.6) 5.2 (1.0) 4.7 (1.2) 4.7 (1.2) 4.8 (1.1)
HDL cholesterol (mmol.L-1) 1.2 (0.2) 1.3 (0.2) 1.1 (0.1) 1.1 (0.3) 1.1 (0.3) 1.1 (0.2)
LDL cholesterol (mmol.L-1) 3.3 (0.9) 3.4 (0.7) 3.2 (0.9) 3.0 (1.1) 3.0 (1.1) 3.1 (1.1)
Triglycerides (mmol.L-1) 1.9 (1.1) 1.7 (0.7) 1.8 (0.8) 1.6 (0.7) 1.6 (0.7) 1.7 (0.7)
hs- CRP (mg/l) 6.2 (5.4) 6.0 (5.7) 6.3 (7.5) 4.6 (5.0) 4.6 (5.0) 4.6 (5.1)
Homocysteine (μmol/l) 11.7 (6.8) 11.2 (3.6) 11.7 (5.1) 12.1 (4.5) 12.1 (4.6) 12.2 (4.6)
Glucose (mmol.L-1) 5.9 (0.9) 5.7 (0.6) 5.6 (0.7) 6.1 (1.0) 6.1 (1.0) 6.0 (0.8)
% HbA1c 5.9 (0.3) 5.9 (0.3) 5.7 (0.4) 6.0 (0.5) 6.0 (0.5) 6.2 (1.1)
Systolic BP (mmHg) 143.0 (26.2) 139.2 (20.6) 141.5 (16.9) 141.4 (12.7) 143.2 (12.8) 136.2 (15.4)
Diastolic BP (mmHg) 90.5 (11.6) 88.3 (11.2) 90.3 (11.9) 88.9 (8.6) 90.7 (10) 89.6 (12.7)
  1. Values are means ± SD. indicates within group differences as a function of time from baseline (p < 0.05)